Kevin R. Alliston

1.5k total citations
38 papers, 1.2k citations indexed

About

Kevin R. Alliston is a scholar working on Infectious Diseases, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kevin R. Alliston has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 11 papers in Cancer Research and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kevin R. Alliston's work include Viral gastroenteritis research and epidemiology (15 papers), Protease and Inhibitor Mechanisms (11 papers) and Viral Infections and Immunology Research (9 papers). Kevin R. Alliston is often cited by papers focused on Viral gastroenteritis research and epidemiology (15 papers), Protease and Inhibitor Mechanisms (11 papers) and Viral Infections and Immunology Research (9 papers). Kevin R. Alliston collaborates with scholars based in United States. Kevin R. Alliston's co-authors include William C. Groutas, Yunjeong Kim, Sivakoteswara Rao Mandadapu, Dengfeng Dou, Gerald H. Lushington, Kyeong‐Ok Chang, Scott Lovell, K.P. Battaile, Kyeong-Ok Chang and Huiguo Lai and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Virology.

In The Last Decade

Kevin R. Alliston

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin R. Alliston United States 21 521 319 300 282 171 38 1.2k
Kumar Singh Saikatendu United States 15 775 1.5× 58 0.2× 582 1.9× 95 0.3× 206 1.2× 21 1.4k
Christin Müller Germany 19 373 0.7× 70 0.2× 412 1.4× 72 0.3× 86 0.5× 35 1.0k
Jin-Hua Sun United States 24 607 1.2× 166 0.5× 427 1.4× 124 0.4× 48 0.3× 34 2.0k
Angela M. Lam United States 27 1.1k 2.1× 246 0.8× 913 3.0× 128 0.5× 71 0.4× 61 2.7k
Mika Okamoto Japan 21 661 1.3× 338 1.1× 642 2.1× 46 0.2× 47 0.3× 65 2.0k
Jyh‐Haur Chern Taiwan 18 311 0.6× 291 0.9× 318 1.1× 344 1.2× 63 0.4× 29 1.0k
Tsuyoshi Adachi Japan 12 305 0.6× 177 0.6× 370 1.2× 106 0.4× 84 0.5× 20 1.2k
Susan L. Binford United States 12 408 0.8× 183 0.6× 420 1.4× 528 1.9× 113 0.7× 15 1.1k
Edward L. Brown United States 9 252 0.5× 202 0.6× 332 1.1× 319 1.1× 121 0.7× 10 754
Manos Perros United Kingdom 21 1.3k 2.5× 228 0.7× 688 2.3× 37 0.1× 116 0.7× 35 2.5k

Countries citing papers authored by Kevin R. Alliston

Since Specialization
Citations

This map shows the geographic impact of Kevin R. Alliston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin R. Alliston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin R. Alliston more than expected).

Fields of papers citing papers by Kevin R. Alliston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin R. Alliston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin R. Alliston. The network helps show where Kevin R. Alliston may publish in the future.

Co-authorship network of co-authors of Kevin R. Alliston

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin R. Alliston. A scholar is included among the top collaborators of Kevin R. Alliston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin R. Alliston. Kevin R. Alliston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mandadapu, Sivakoteswara Rao, Pathum M. Weerawarna, Allan M. Prior, et al.. (2013). Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus. Bioorganic & Medicinal Chemistry Letters. 23(13). 3709–3712. 37 indexed citations
2.
Prior, Allan M., Yunjeong Kim, Sahani Weerasekara, et al.. (2013). Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(23). 6317–6320. 46 indexed citations
3.
Mandadapu, Sivakoteswara Rao, Allan M. Prior, Kevin R. Alliston, et al.. (2012). Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(1). 62–65. 36 indexed citations
4.
Dou, Dengfeng, Sivakoteswara Rao Mandadapu, Kevin R. Alliston, et al.. (2012). Potent norovirus inhibitors based on the acyclic sulfamide scaffold. Bioorganic & Medicinal Chemistry. 20(6). 2111–2118. 16 indexed citations
5.
Lai, Huiguo, T Teramoto, Kevin R. Alliston, et al.. (2012). Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold. Bioorganic & Medicinal Chemistry. 20(13). 4140–4148. 39 indexed citations
6.
Dou, Dengfeng, Sivakoteswara Rao Mandadapu, Kevin R. Alliston, et al.. (2011). Design and synthesis of inhibitors of noroviruses by scaffold hopping. Bioorganic & Medicinal Chemistry. 19(19). 5749–5755. 23 indexed citations
7.
Dou, Dengfeng, Sivakoteswara Rao Mandadapu, Kevin R. Alliston, et al.. (2011). Potent inhibition of Norwalk virus by cyclic sulfamide derivatives. Bioorganic & Medicinal Chemistry. 19(20). 5975–5983. 25 indexed citations
8.
Mandadapu, Sivakoteswara Rao, Kevin R. Alliston, Gerald H. Lushington, et al.. (2011). Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease. Bioorganic & Medicinal Chemistry Letters. 21(18). 5315–5319. 47 indexed citations
9.
Dou, Dengfeng, Yi Li, Zhong Lai, et al.. (2009). Utilization of the 1,2,3,5-thiatriazolidin-3-one 1,1-dioxide scaffold in the design of potential inhibitors of human neutrophil proteinase 3. Bioorganic & Medicinal Chemistry. 18(3). 1093–1102. 17 indexed citations
10.
Yang, Qingliang, Yi Li, Dengfeng Dou, et al.. (2008). Inhibition of serine proteases by a new class of cyclosulfamide-based carbamylating agents. Archives of Biochemistry and Biophysics. 475(2). 115–120. 14 indexed citations
11.
Li, Yi, Qingliang Yang, Dengfeng Dou, Kevin R. Alliston, & William C. Groutas. (2007). Inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamides. Bioorganic & Medicinal Chemistry. 16(2). 692–698. 11 indexed citations
12.
Alliston, Kevin R., et al.. (2006). Epoxy paint failure in B-52 fuel tanks. Progress in Organic Coatings. 56(4). 285–296. 5 indexed citations
13.
Mohan, Swathi, et al.. (2005). 1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase. Archives of Biochemistry and Biophysics. 436(1). 1–7. 8 indexed citations
14.
Wei, Liuqing, Zhong Lai, Kevin R. Alliston, et al.. (2004). Mechanism-based inactivation of human leukocyte elastase via an enzyme-induced sulfonamide fragmentation process. Archives of Biochemistry and Biophysics. 429(1). 60–70. 5 indexed citations
15.
Zhong, Jiaying, Zhong Lai, Kevin R. Alliston, et al.. (2004). Serendipitous discovery of an unexpected rearrangement leads to two new classes of potential protease inhibitors. Bioorganic & Medicinal Chemistry. 12(23). 6249–6254. 1 indexed citations
16.
Zhong, Jiaying, et al.. (2004). Potential Protease Inhibitors Based on a Functional Cyclic Sulfamide Scaffold.. ChemInform. 35(44). 1 indexed citations
17.
Lai, Zhong, et al.. (2004). Potent inhibition of human leukocyte elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamide derivatives. Archives of Biochemistry and Biophysics. 429(2). 191–197. 17 indexed citations
18.
Zhong, Jiaying, et al.. (2003). Design, synthesis, and in vitro evaluation of inhibitors of human leukocyte elastase based on a functionalized cyclic sulfamide scaffold. Bioorganic & Medicinal Chemistry. 12(3). 589–593. 23 indexed citations
19.
Wei, Liuqing, et al.. (2003). Noncovalent inhibitors of human leukocyte elastase based on the 4-imidazolidinone scaffold. Bioorganic & Medicinal Chemistry. 11(23). 5149–5153. 10 indexed citations
20.
Wimalasena, Kandatege, et al.. (1997). Chiral Multisubstrate Inhibitors of Dopamine β-Monooxygenase:  Evidence for Dual Modes of Interaction. Biochemistry. 36(23). 7144–7153. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kumar Singh Saikatendu Breakdown of academic impact, for papers by Christin Müller Breakdown of academic impact, for papers by Jin-Hua Sun Breakdown of academic impact, for papers by Angela M. Lam Breakdown of academic impact, for papers by Mika Okamoto Breakdown of academic impact, for papers by Jyh‐Haur Chern Breakdown of academic impact, for papers by Tsuyoshi Adachi Breakdown of academic impact, for papers by Susan L. Binford Breakdown of academic impact, for papers by Edward L. Brown Breakdown of academic impact, for papers by Manos Perros
Rankless by CCL
2026